CNBC’s Meg Tirrell offers an update on the war of words between Mallinckrodt and Citron Research.
Mallinckrodt fires back at Citron
Citron targets Mallinckrodt
Citron Research tweeted about Mallinckrodt, stating the stock has significant more downside than Valeant at these prices. Citron executive editor Andrew Left, provides insight to the tweet.
Mallinckrodt in the crosshairs
CNBC’s Meg Tirrell reports Mallinckrodt is in sight of short seller Citron Research.
Citron’s latest target
CNBC’s Meg Tirrell highlights the short-seller’s next target in the biotech space.
Mallinckrodt responds to Citron accusations
CNBC’s Seema Mody shares a statement from Mallinckrodt discussing its growth strategy.